Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Assets
Loans receivable	$ 66,859,733	$ 73,048,403
Interest and other fees receivable on loans	1,488,784	1,395,905
Cash	105,929	104,222
Cash - restricted		1,587,773
Other assets	134,321	63,636
Right-of-use asset - operating lease, net	180,446	207,364
Deferred financing costs, net	23,101	27,583
Total assets	68,792,314	76,434,886
Liabilities:
Line of credit	17,345,510	25,152,338
Senior secured notes (net of deferred financing costs of $134,528 and $172,069, respectively)	5,865,472	5,827,931
Deferred origination fees	646,027	719,019
Accounts payable and accrued expenses	242,248	295,292
Operating lease liability	193,800	220,527
Dividends payable	1,315,445	1,287,073
Total liabilities	25,608,502	33,502,180
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 and 11,440,651 outstanding, respectively	11,757	11,757
Additional paid-in capital	45,555,408	45,548,876
Less: Treasury stock, at cost – 318,407 and 316,407 shares, respectively	(1,070,406)	(1,060,606)
Accumulated deficit	(1,312,947)	(1,567,321)
Total stockholders’ equity	43,183,812	42,932,706
Total liabilities and stockholders’ equity	$ 68,792,314	$ 76,434,886